skip to main content

TFR Molecular Relapse — RACP Adult Medicine MCQ

Instant feedback + full explanation. One question, done properly.

ModerateHaematologyTFR Molecular RelapseRACP Adult Medicine

A 55-year-old woman on CML imatinib for 8 years attempts TFR. What happens in ~50% of patients who attempt TFR?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CBCR-ABL1 becomes detectable requiring TKI restart

~50% have molecular relapse on TFR but >95% regain response when TKI is restarted. Monthly molecular monitoring is essential.

Reference: eTG – 2025 – Haematology; ELN – 2020; EURO-SKI